CE Mark Approval for Direct Aortic Approach
Medtronic CoreValve System is the Only System Approved for Three Transarterial Approaches
Direct aortic implantaion of the CoreValve system expands opportunities for heart teams to offer transcatheter aortic valve replacement procedures to more patients. Direct aortic implantation with the Medtronic CoreValve System uses:
• Familiar surgical access routes that do not require pericardial dissection or direct heart muscle manipulation.
• A familiar delivery system specifically designed for retrograde implantation — with an ataumatic, tapered tip and a consistent valve loading procedure across access approaches.
• A proven device platform implanted in over 20,000 patients worldwide with published 4-year clinical data.
Initial direct aortic clinical experience demonstrates high procedural success rate and a low incidence of vascular complications similar to transfemoral and subclavian approaches.